| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J2323 |
Natalizumab injection |
1,658 |
1,540 |
$11.38M |
| J0585 |
Injection,onabotulinumtoxina |
5,781 |
5,687 |
$7.18M |
| J1726 |
Makena, 10 mg |
1,101 |
986 |
$3.16M |
| J0897 |
Denosumab injection |
1,003 |
980 |
$1.29M |
| J2315 |
Naltrexone, depot form |
521 |
499 |
$699K |
| J0517 |
Inj., benralizumab, 1 mg |
87 |
81 |
$416K |
| Q9991 |
Buprenorph xr 100 mg or less |
203 |
190 |
$320K |
| J7324 |
Orthovisc inj per dose |
95 |
95 |
$259K |
| J7323 |
Euflexxa inj per dose |
185 |
168 |
$239K |
| Q9992 |
Buprenorphine xr over 100 mg |
88 |
88 |
$141K |
| J1729 |
Inj hydroxyprogst capoat nos |
41 |
40 |
$89K |
| J3590 |
Unclassified biologics |
12 |
12 |
$87K |
| J2182 |
Injection, mepolizumab, 1mg |
21 |
13 |
$40K |
| J2790 |
Rho d immune globulin inj |
223 |
223 |
$23K |
| Q0512 |
Px sup fee anti-can sub pres |
460 |
359 |
$0.00 |
| J7517 |
Mycophenolate mofetil oral |
38 |
38 |
$0.00 |
| Q0511 |
Sup fee antiem,antica,immuno |
305 |
289 |
$0.00 |
| J7518 |
Mycophenolic acid |
124 |
108 |
$0.00 |
| J7507 |
Tacrolimus imme rel oral 1mg |
275 |
245 |
$0.00 |